Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats - Test2 - elhamkhani - TriplyDB

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

http://www.wikidata.org/entity/Q29619737

about

Acute ethanol treatment upregulates Th1, Th2, and Hdc in larval zebrafish in stable networks Exercise-based treatments for substance use disorders: evidence, theory, and practicality Amphetamine, past and present--a pharmacological and clinical perspective Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms Neuropharmacology of alcohol addiction Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants Addiction science: Uncovering neurobiological complexity Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.Antipsychotic medications for cocaine dependence Anticonvulsants for cocaine dependence Anticonvulsants for cocaine dependence Dopamine agonists for the treatment of cocaine dependence Anticonvulsants for alcohol dependence Dopamine agonists for the treatment of cocaine dependence Antidepressants for cocaine dependence and problematic cocaine use Antidepressants for cocaine dependence Disulfiram for the treatment of cocaine dependence Anticonvulsants for cocaine dependence Anticonvulsants for cocaine dependence Antipsychotic medications for cocaine dependence Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter Cannabinoid receptor localization in brain Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory How addictive drugs disrupt presynaptic dopamine neurotransmission A Nicotine Challenge to the Self-Medication Hypothesis in a Neurodevelopmental Animal Model of Schizophrenia Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system Neurocircuitry of addiction Kappa opioids as potential treatments for stimulant dependence Long-lasting alteration in mesocorticolimbic structures after repeated social defeat stress in rats: time course of mu-opioid receptor mRNA and FosB/DeltaFosB immunoreactivity Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake Kappa-opioid ligands in the study and treatment of mood disorders Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence Marijuana and cannabinoid regulation of brain reward circuits Actions of cocaine on rat dopaminergic neurones in vitro

P2860

Q21558412-815334B4-41B3-47A3-9972-4F9D409E5B3D Q22241262-A2B32B7B-B7B9-4897-AA08-4DF5CA853898 Q22241826-A416D1B4-0837-47BF-B137-C21D86C96EAC Q22241964-6DDFE634-C59F-4D38-9D99-C004457F3317 Q22248047-0E0322CE-83C3-431B-8B06-DD0411FC0961 Q22251110-17681D12-BFF6-4A1A-81A1-5DB3E4754874 Q22251215-A4823CA9-F291-456E-BCDF-B42F9A40B7FD Q22251251-1EE4D3E2-87F9-468D-86D7-778AF4A994B7 Q22251269-C988738A-A469-48AC-A40A-988965C0BF51 Q24186021-C5C6266E-E5F0-4385-AD41-8C2F7BB74EDA Q24186475-ABE19209-48C3-443D-8B74-9092547AA039 Q24187487-9508C1F8-543C-4345-9661-CAA22D5C2999 Q24187799-403F6C74-785D-43A5-9204-16449CC303BB Q24200396-C3B343B7-6987-4B8C-BCF9-DF5B7F23879D Q24234240-927C67DF-598C-493B-AFA3-4E1F38C9C01C Q24234248-FF27804F-15DC-4CB8-9CC5-BF3359807691 Q24240094-389ACA39-DB62-4D7D-9822-EDAD191D2BB5 Q24240796-0399365C-2810-406F-B945-6F51EE3826F2 Q24242962-5DDB104A-E4D4-46AF-A988-55D85E78A716 Q24243785-F2AD8A42-4D89-4729-BA1A-C769FEC9E5EA Q24243837-A2991E80-D68C-4AA7-9BBD-B057A2946C7F Q24548521-F8041CE5-2CEC-4903-8530-0D34C818CADA Q24558751-ACA4F1E4-20B3-40E1-9DBF-94A9E5AC7DA9 Q24600288-F50D0B95-9700-4A25-94B1-6F5D149FB324 Q24603526-94DCD895-4BE6-44DD-A67C-DA75753B9F13 Q24613576-EEACD10E-DB0D-45C2-B4F6-46F4444725DE Q24625428-3DC5F570-6CD5-4AE8-B557-C3915315B363 Q24631269-141DBF82-FE47-42D8-A14E-69E94E74FEAF Q24634186-DE3AB48A-2B63-458C-9EE3-1B9F28F61126 Q24644809-0B475EF4-CA66-4B7D-A537-3BC7D3687575 Q24646604-DD947292-1C0F-487E-A022-ABF8C28D001E Q24647156-40F79651-EFA9-4846-9EB5-B551BEABD774 Q24647849-1638379D-E92C-4BA3-85C1-DE29C2CA8888 Q24648008-F69BD652-2820-46DD-B934-2CB19355172C Q24650110-6D9A5472-2DD1-41EE-9D4E-FD2347BE70F0 Q24651508-77560756-ABB4-4A0B-8F3F-E455758C37A9 Q24657982-B5409904-B63E-4768-951A-0AB17DE15A7B Q24658266-341E4748-5230-40C7-910B-500698807A52 Q24671514-05DB637E-1967-47F0-94BA-A945D8CC6118 Q24673575-3072267F-0A20-4FC9-B093-1D00BEFAD8B5

P2860

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

http://www.wikidata.org/entity/Q29619737

description

1988 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

article publié dans les Procee ...... f the United States of America

@fr

artículu científicu espublizáu en 1988

@ast

im Juli 1988 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: July 1988)

@en

wetenschappelijk artikel (gepubliceerd in 1988-07)

@nl

наукова стаття, опублікована в липні 1988

@uk

مقالة علمية (نشرت في يوليو 1988)

@ar

name

Drugs abused by humans prefere ...... c system of freely moving rats

@ast

Drugs abused by humans prefere ...... c system of freely moving rats

@en

type

label

Drugs abused by humans prefere ...... c system of freely moving rats

@ast

Drugs abused by humans prefere ...... c system of freely moving rats

@en

prefLabel

Drugs abused by humans prefere ...... c system of freely moving rats

@ast

Drugs abused by humans prefere ...... c system of freely moving rats

@en

P1433

Q29619737-AD50A0F3-6E6A-47A3-AC5D-E3F41EF7926D

P1476

Q29619737-B477EF41-9C66-4C86-B53A-49BC679CB16A

P2093

Q29619737-2FD63665-147A-4E47-AF88-CCEB095DB36F

Q29619737-F5CB0DC5-1DE3-4F24-BECF-16201CA91A8F

P2860

Q29619737-031D8D6A-13DB-4D07-AD08-C24A662C79A2

Q29619737-06B59892-1E27-4FE0-98BB-29828A94DFE9

Q29619737-06EA7D7A-1A07-4D4F-9DD7-30FDFDE4F7AC

Q29619737-0CD52676-68F2-4293-A48A-4E893031934E

Q29619737-0D0D3DB0-2DF9-4DE6-8B6D-644D4456DB5B

Q29619737-2B1B00FF-EEE6-449A-9C9D-AF8B8CFC3C32

Q29619737-2CE4D088-6CEF-44FB-B920-021398D36C5E

Q29619737-35B85CE7-C8CF-4691-85A7-2844D9D3248A

Q29619737-36D52CF0-4F62-4411-95EC-A4DB4B9D4630

Q29619737-36EA9D3F-1B3E-49AD-A6A3-FA2B55291663

P304

Q29619737-B0C50960-550F-407A-B62A-AE4E0AFD6F57

P31

Q29619737-4987D096-5F9F-4AE9-BF83-CCCDF27BF48B

P3181

Q29619737-75014824-6596-4375-99EC-87127FAF334E

P356

Q29619737-765A2797-EF11-4D3A-9E3E-5DC6D60A5154

P407

Q29619737-DB9C1788-0D00-41E1-8A51-8DA5779C40D8

P433

Q29619737-EFCE0778-5A84-47FF-A7E9-78DD72E6CF1A

P478

Q29619737-DD694C52-5C16-4A7F-8CAC-935C9507344B

P577

Q29619737-D8B9BC1D-50DA-4A55-9B8F-6125530BBC04

P5875

Q29619737-D2F0A1AE-1A60-4274-92CF-3B85BF919789

P698

Q29619737-6F75534D-0848-464E-8518-35EB3CCC94B5

P921

Q29619737-0e8e0957-cb2f-4ef6-8075-7d202b6221ca

P932

Q29619737-FFA69E10-EC11-4B2D-8F9D-1EC353B7E98B

P3181

P356

PNAS.85.14.5274

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Drugs abused by humans prefere ...... c system of freely moving rats

@en

P2093

Di Chiara G

http://www.w3.org/2001/XMLSchema#string

Imperato A

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning.

Some determinants of the motivational properties of ethanol in the rat: concurrent administration of food or social stimuli.

Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats.

Electrophysiological actions of nicotine on substantia nigra single units.

U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.

Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys.

Preference conditioning produced by opioid active and inactive isomers of levorphanol and morphine in rat.

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.

An opioid benzodiazepine.

P304

5274-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

812913

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.85.14.5274

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

1988-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20257585

http://www.w3.org/2001/XMLSchema#string

P698

2899326

http://www.w3.org/2001/XMLSchema#string

P921

P932

281732

http://www.w3.org/2001/XMLSchema#string